Viking Therapeutics, Inc. (VKTX)
27.28
+0.42
(+1.56%)
USD |
NASDAQ |
Oct 30, 16:00
26.99
-0.29
(-1.06%)
Pre-Market: 20:00
Viking Therapeutics 30-Day Average Daily Volume : 8.120M for Oct. 30, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 30, 2026 | 8.120M |
| October 29, 2026 | 8.038M |
| October 28, 2026 | 7.882M |
| October 27, 2026 | 7.842M |
| October 26, 2026 | 7.825M |
| October 23, 2026 | 7.767M |
| October 22, 2026 | 7.685M |
| October 21, 2026 | 7.625M |
| October 20, 2026 | 7.583M |
| October 19, 2026 | 7.490M |
| October 16, 2026 | 7.412M |
| October 15, 2026 | 7.206M |
| October 14, 2026 | 7.084M |
| October 13, 2026 | 6.921M |
| October 12, 2026 | 6.789M |
| October 09, 2026 | 6.773M |
| October 08, 2026 | 6.711M |
| October 07, 2026 | 6.458M |
| October 06, 2026 | 6.348M |
| October 05, 2026 | 6.169M |
| October 02, 2026 | 6.010M |
| October 01, 2026 | 5.854M |
| September 30, 2026 | 5.715M |
| September 29, 2026 | 5.522M |
| September 28, 2026 | 5.305M |
| Date | Value |
|---|---|
| September 25, 2026 | 5.059M |
| September 24, 2026 | 4.730M |
| September 23, 2026 | 3.822M |
| September 22, 2026 | 3.331M |
| September 21, 2026 | 2.011M |
| September 18, 2026 | 1.888M |
| September 17, 2026 | 1.842M |
| September 16, 2026 | 1.838M |
| September 15, 2026 | 1.795M |
| September 14, 2026 | 1.754M |
| September 11, 2026 | 1.755M |
| September 10, 2026 | 1.798M |
| September 09, 2026 | 1.838M |
| September 08, 2026 | 1.847M |
| September 04, 2026 | 1.848M |
| September 03, 2026 | 1.863M |
| September 02, 2026 | 1.924M |
| September 01, 2026 | 1.917M |
| August 31, 2026 | 1.920M |
| August 28, 2026 | 1.925M |
| August 27, 2026 | 1.910M |
| August 26, 2026 | 1.887M |
| August 25, 2026 | 1.890M |
| August 24, 2026 | 1.865M |
| August 21, 2026 | 1.873M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Eli Lilly & Co. | 2.448M |
| Ironwood Pharmaceuticals, Inc. | 1.805M |
| Compass Therapeutics, Inc. | 5.563M |
| Structure Therapeutics, Inc. | 1.298M |
| Amgen, Inc. | 2.742M |